Meeting Report: Third ESWI Science Policy Interface Roundtable, Bucharest (22 October 2026)
Consistent messaging, collaboration and a clear way forward needed to strengthen prevention in Romania
|
Shaping the Future of Respiratory Virus Research
Understanding the Transmission of Respiratory Viruses
How do we detect infections that might otherwise go unnoticed? And what can we learn about immunity where these viruses enter the body? These key questions, among many others, are expertly explored and explained by Dr Nicole Tsang and Dr Kevin Selva.
The Economic Case for Pandemic Preparedness and Response: Beyond Lockdowns
Focus on 8 non-pharmaceutical interventions (NPIs) for community infection prevention and control.
In the media
News
Partner Organisations
Call to Action - "Immunisation for a Resilient Europe: From EU Commitment to National Action" (MBVE)
A call to EU institutions and Member States
UN General Assembly adopts pandemic declaration, but not by consensus
Political declaration on pandemic prevention, preparedness & response was adopted by 153 in favour to 3 against (Argentina, Israel, US) with 2 abstentions (New Zealand, Paraguay).
Commission adopts EUR 680 million EU4Health work programme 2026
The Commission has adopted the EUR 680 million EU4Health Work Programme for 2026, following a positive opinion by Member States.
Adult Respiratory Vaccination Delivers Up to $12 in Societal Value for Every $1 Spent, Analysis Finds
Benefit-cost modeling estimated $22B annual spend produces $101B-$241B net benefits, preventing ~18,500 deaths and 300,000 hospitalizations in a single year.
Beyond childhood: why lifelong vaccination is a frontline defence against chronic disease
Guest article by the World Federation of Public Health Associations (WFPHA)